Cargando…
Tumor biomarkers predict clinical outcome of COVID-19 patients
Autores principales: | He, Bangshun, Zhong, Aifang, Wu, Qiuyue, Liu, Xiong, Lin, Jie, Chen, Chao, He, Yiming, Guo, Yanju, Zhang, Man, Zhu, Peiran, Wu, Jian, Wang, Changjun, Wang, Shukui, Xia, Xinyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289104/ https://www.ncbi.nlm.nih.gov/pubmed/32504736 http://dx.doi.org/10.1016/j.jinf.2020.05.069 |
Ejemplares similares
-
Potential False-Positive and False-Negative Results for COVID-19 IgG/IgM Antibody Testing After Heat-Inactivation
por: Lin, Jie, et al.
Publicado: (2021) -
Clinical efficacy of convalescent plasma therapy on treating COVID‐19 patients: Evidence from matched study and a meta‐analysis
por: Jiang, Weijun, et al.
Publicado: (2020) -
IGF2 loss of imprinting enhances colorectal cancer stem cells pluripotency by promoting tumor autophagy
por: Gao, Tianyi, et al.
Publicado: (2020) -
Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis
por: Jiang, Weijun, et al.
Publicado: (2021) -
The diagnostic and prognostic values of microRNA-196a in cancer
por: Xiong, Mengqiu, et al.
Publicado: (2021)